Comparison of the Antiviral Activity of Remdesivir, Chloroquine, and Interferon-β as Single or Dual Agents Against the Human Beta-Coronavirus OC43
Open Access
- 1 January 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 43 (1), 35-42
- https://doi.org/10.1089/jir.2022.0210
Abstract
The human beta-coronavirus strain, OC43, provides a useful model for testing the antiviral activity of various agents. We compared the activity of several antiviral drugs against OC43, including remdesivir, chloroquine, interferon (IFN)-β, IFN-λ1, and IFN-λ4, in two distinct cell types: human colorectal carcinoma cell line (HCT-8 cells) and normal human bronchial epithelial (NHBE) cells. We also tested whether these agents mediate additive, synergistic, or antagonistic activity against OC43 infection when used in combination. When used as single agents, remdesivir exhibited stronger antiviral activity than chloroquine, and IFN-β exhibited stronger activity than IFN-λ1 or IFN-λ4 against OC43 in both HCT-8 and NHBE cells. Anakinra (IL-1 inhibitor) and tocilizumab (IL-6 inhibitor) did not mediate any antiviral activity. The combination of IFN-β plus chloroquine or remdesivir resulted in higher synergy scores and higher expression of IFN-stimulated genes than did IFN-β alone. In contrast, the combination of remdesivir plus chloroquine resulted in an antagonistic interaction in NHBE cells. Our findings indicate that the combined use of IFN-β plus remdesivir or chloroquine induces maximal antiviral activity against human coronavirus strain OC43 in primary human respiratory epithelial cells. Furthermore, our experimental OC43 virus infection model provides an excellent method for evaluating the biological activity of antiviral drugs.Keywords
This publication has 30 references indexed in Scilit:
- Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymeraseAntiviral Research, 2019
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency ModelComputational and Structural Biotechnology Journal, 2015
- Characterization of Human Coronavirus OC43 and Human Coronavirus NL63 Infections Among Hospitalized Children <5 Years of AgeThe Pediatric Infectious Disease Journal, 2014
- Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytesJournal of Leukocyte Biology, 2012
- Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn MiceAntimicrobial Agents and Chemotherapy, 2009
- Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERKAntiviral Research, 2008
- An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-Reactivity with SARS CoronavirusCanadian Journal of Infectious Diseases and Medical Microbiology, 2006
- Chloroquine is a potent inhibitor of SARS coronavirus infection and spreadVirology Journal, 2005
- Human and avian influenza viruses target different cell types in cultures of human airway epitheliumProceedings of the National Academy of Sciences of the United States of America, 2004
- Vacuolating encephalitis in mice infected by human coronavirus OC43Virology, 2003